Provided by Tiger Fintech (Singapore) Pte. Ltd.

AEON Biopharma

0.4304
-0.0296-6.43%
Post-market: 0.43990.0095+2.21%19:58 EDT
Volume:215.36K
Turnover:96.79K
Market Cap:4.53M
PE:0.01
High:0.4672
Open:0.4672
Low:0.4302
Close:0.4600
Loading ...
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 02, 2024

Correspondence

Form CORRESP - Correspondence
Jul 29, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 23, 2024

Correspondence

Form CORRESP - Correspondence
Jul 09, 2024

Correspondence

Form CORRESP - Correspondence
Jul 09, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Major Issues Report

Form 8-K - Current report
May 31, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 31, 2024

Correspondence

Form CORRESP - Correspondence
May 16, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

[Rev.]Annual Report

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 24, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Nov 13, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 13, 2023

Major Issues Report

Form 8-K - Current report
Oct 23, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Oct 19, 2023

Major Issues Report

Form 8-K - Current report
Oct 03, 2023

Major Issues Report

Form 8-K - Current report